ACSNX Performance — Short Duration Fund, Investor Class
Data updated: 2026-08-28
ACSNX returned +1.10% year to date and +3.57% over one year to Jun 2026. Annualised returns are +5.04% over 3 years and +2.32% over 5 years. The fund trailed its Short-Term Core Bond category average: $100 invested three years ago grew to $116, against $118 for the category, and to $104 over one year, against $104. Volatility over the past three years was 1.58% a year. In the 12 months to Jun 2026 the fund lost a net $129.1M, and assets reached $1.01B.
ACSNX Growth of $100
What $100 invested in Short Duration Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Short-Term Core Bond category average over the same months.
| Period | ACSNX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $104 | $104 |
| 3 years (Jul 2023 – Jun 2026) | $116 | $118 |
| 5 years (Jul 2021 – Jun 2026) | $112 | $113 |
| Since data start (Jul 2019 – Jun 2026) | $119 | $122 |
ACSNX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.10% |
| 1 year | +3.57% |
| 3 years (annualised) | +5.04% |
| 5 years (annualised) | +2.32% |
ACSNX Annual Returns
Calendar-year total returns of Short Duration Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +1.10% |
| 2025 | +5.62% |
| 2024 | +4.68% |
| 2023 | +4.70% |
| 2022 | −4.17% |
| 2021 | +1.02% |
| 2020 | +4.02% |
| 2019 (Jul–Dec) | +0.98% |
ACSNX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.4% | +0.5% | −0.6% | +0.5% | +0.2% | +0.1% | — | — | — | — | — | — |
| 2025 | +0.5% | +0.7% | +0.2% | +0.6% | +0.2% | +0.9% | +0.1% | +0.8% | +0.4% | +0.4% | +0.5% | +0.4% |
| 2024 | +0.4% | −0.4% | +0.5% | −0.3% | +0.8% | +0.5% | +1.2% | +0.9% | +0.9% | −0.5% | +0.4% | +0.3% |
| 2023 | +0.9% | −0.4% | +1.1% | +0.4% | −0.4% | −0.6% | +0.4% | +0.4% | −0.2% | +0.3% | +1.3% | +1.4% |
| 2022 | −0.6% | −0.7% | −1.4% | −0.3% | +0.2% | −1.0% | +0.5% | −0.4% | −1.2% | −0.3% | +0.7% | +0.4% |
| 2021 | +0.3% | +0.1% | +0.1% | +0.3% | +0.2% | 0.0% | +0.2% | 0.0% | +0.1% | −0.2% | −0.2% | 0.0% |
| 2020 | +0.6% | +0.5% | −2.2% | +1.5% | +1.1% | +0.4% | +0.5% | +0.3% | 0.0% | +0.1% | +0.5% | +0.5% |
| 2019 | — | — | — | — | — | — | −0.1% | +0.8% | −0.2% | +0.3% | 0.0% | +0.2% |
ACSNX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 1.58%
- 3-year Sharpe ratio: 0.34 (vs 4.5% risk-free rate)
- Best month: +1.41% (Dec 2023)
- Worst month: −0.55% (Mar 2026)
ACSNX Fund Flows
Monthly money in and out of Short Duration Fund, from SEC Form N-PORT.
- 12-month net flow: −$129.1M
- 12-month gross sales (incl. reinvestments): $193.6M
- Sales ÷ redemptions: 0.60×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $23.9M | $12.0M | $11.9M |
| May 2026 | $15.8M | $8.0M | $7.7M |
| Apr 2026 | $8.9M | $17.8M | −$8.9M |
| Mar 2026 | $13.6M | $41.9M | −$28.2M |
| Feb 2026 | $15.1M | $16.1M | −$1.0M |
| Jan 2026 | $10.8M | $17.1M | −$6.3M |
| Dec 2025 | $20.0M | $40.7M | −$20.7M |
| Nov 2025 | $10.6M | $25.1M | −$14.5M |
| Oct 2025 | $15.3M | $36.6M | −$21.2M |
| Sep 2025 | $17.3M | $79.8M | −$62.5M |
| Aug 2025 | $31.2M | $17.4M | $13.8M |
| Jul 2025 | $11.1M | $10.3M | $837K |
ACSNX Assets Under Management
Net assets of Short Duration Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.01B |
| 2026-03-31 | $1.00B |
| 2025-12-31 | $1.05B |
| 2025-09-30 | $1.10B |
| 2025-06-30 | $1.15B |
| 2025-03-31 | $1.15B |
| 2024-12-31 | $1.20B |
| 2024-09-30 | $1.34B |
| 2024-06-30 | $1.31B |
| 2024-03-31 | $1.35B |
| 2023-12-31 | $1.39B |
| 2023-09-30 | $1.36B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.